Key result
Pragmatic strategies, including optimized documentation, assistance programs, and multidisciplinary care, are essential to overcome barriers in the implementation of cardiometabolic therapies.
Why the study?
Despite strong evidence supporting guideline-directed cardiometabolic therapies, uptake remains low due to clinical inertia, therapeutic complexity, prior authorizations, and cost.
Overcoming implementation barriers through pragmatic strategies and multidisciplinary care is essential to realize the benefits of novel cardiometabolic therapies.
Answers are grounded in this paper and cite their sources.
Strong evidence supports cardiometabolic therapies across overlapping conditions; extends synthesis but leaves optimal combinations open for trials.
Cardiometabolic conditions, including type 2 diabetes, atherosclerotic cardiovascular disease, heart failure, and chronic kidney disease, affect more than 100 million adults in the United States, and are major drivers of morbidity, mortality, and health care costs. Despite strong evidence supporting glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, nonsteroidal mineralocorticoid receptor antagonists, and proprotein convertase subtilisin/kexin type 9-directed inhibitors, uptake remains low. Barriers include clinical inertia, therapeutic complexity, prior authorization requirements, and cost-related challenges. This review outlines these barriers as well as pragmatic strategies to improve prescription, access, and adherence, including optimized documentation, copay assistance programs, patient assistance programs, and integration of electronic tools. Multidisciplinary care models may further improve implementation, especially for medically complex patients. Addressing implementation barriers at the provider, system, and policy levels is essential to realizing the full potential of these pluripotent therapies and reducing disparities in cardiometabolic care.
No takes yet. Share an insight, caveat, or question.
Eyadiel et al. (2025) conducted a review in Cardiometabolic conditions. Pragmatic strategies to overcome implementation barriers was evaluated. Pragmatic strategies, including optimized documentation, assistance programs, and multidisciplinary care, are essential to overcome barriers in the implementation of cardiometabolic therapies.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: